Abstract
Introduction to the sessions on 'Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors'
Highlights
Speaking against the motion, Professor Cameron made the point that follow-up policy varied markedly between the UK and North America
He too agreed that there was no clinical trial evidence of the effect on outcome of a policy of regular follow-up versus no follow-up. He emphasized strongly that detailed outcome information is mandatory for all patients enrolled in clinical trials, and that such information is best accrued through regular follow-up
Professor Cameron commented that discontinuing regular follow-up might not improve health economics, because the treatment of recurrence following delayed detection would be considerably more expensive than treatment of recurrence detected at an earlier stage
Summary
Section introduction Introduction to the sessions on ‘Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors’ The motion for debate was, ‘Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors’. Speaking for the motion, Professor Dixon made the point that there is considerable discrepancy between the recommendations for follow-up from the UK and North America.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
